Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function
Open Access
- 15 November 2000
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (10) , 1189-1195
- https://doi.org/10.1172/jci11620
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Nuclease-resistant synthetic ribozymes: developing a new class of therapeuticsJournal of Clinical Investigation, 2000
- Escort aptamers: a delivery service for diagnosis and therapyJournal of Clinical Investigation, 2000
- Design of nuclease resistant protein kinase cα DNA enzymes with potential therapeutic applicationJournal of Molecular Biology, 2000
- Vascular Smooth Muscle Cells Express the Transcriptional Corepressor NAB2 in Response to InjuryThe American Journal of Pathology, 1999
- Vascular Smooth Muscle Cell Proliferation and Regrowth after Mechanical Injury in Vitro Are. Egr-1/NGFI-A-DependentThe American Journal of Pathology, 1999
- Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosomeChemistry & Biology, 1999
- Early Growth Response Factor-1 Induction by Injury Is Triggered by Release and Paracrine Activation by Fibroblast Growth Factor-2The American Journal of Pathology, 1999
- DNA enzymesCurrent Opinion in Chemical Biology, 1998
- Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular InjuryScience, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993